Abstract
Background & Objective: A series of novel derivatives possessing the thiophene moiety were synthesized using ethyl 5'-amino-2,3'-bithiophene-4'-carboxylate as the starting material.
Methods: The new synthesized derivatives were screened as lactate dehydrogenase (LDH) inhibitors. LDH plays an important role in glucose metabolism in cancer cells and can affect tumor genesis and metastasis.
Results: 3-Substituted p-tolylthieno[2,3-d]pyrimidin-4(3H)-ones 4 were the most potent inhibitors in this study compared to Galloflavin reference drug.
Conclusion: Molecular docking studies on the Human Lactate Dehydrogenase active site were carried out on the synthesized compounds and the MolDock scores ranged between -127 to -171.
Keywords: Thiophene derivatives, thieno[2, 3-d]pyrimidin-4(3H)-ones, molecular modeling, lactate dehydrogenase inhibitors, anticancer drug target, tumor genesis.
Graphical Abstract
[1]
Äikiä, M.; Jutila, L.; Salmenperä, T.; Mervaala, E.; Kälviäinen, R. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. Epilepsy Behav., 2006, 8, 750-755.
[2]
Almsherqi, Z.A.; McLachlan, C.S.; Mossop, P.; Deng, Y. Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine. Int. J. Cardiol., 2007, 114, 101-102.
[3]
Hunziker, M.E.; Suehs, B.T.; Bettinger, T.L.; Crismon, L. Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder. Clin. Therapeut., 2005, 27, 1126-1143.
[4]
Waugh, C.D. Tioconazole, In xPharm: The Comprehensive Pharmacology
Reference, edited by S.J. Enna and David B. Bylund, Elsevier,
New York. 2007, Pages 1-4, ISBN 9780080552323.
[5]
Cuyun, L.O.; Kaneko, M.; Takafuta, T.; Satoh, K.; Ohnishi, M.; Yatomi, Y.; Ozaki, Y. Inhibitory effects of ticlopidine on platelet function as assessed by three different methods. Eur. J. Pharm. Sci., 2007, 30, 21-25.
[6]
Aguilar, M.I.; Kuo, R.S.; Freeman, W.D. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation. Neurol. Clin., 2013, 31, 659-675.
[7]
Giardin, J. Anticonvulsant action of tiagabine, a new GABA-uptake inhibitor. J. Epilepsy, 1994, 7, 161-166.
[9]
Chambhare, R.V.; Khadse, B.G.; Bobde, A.S.; Bahekar, R.H. Synthesis and preliminary evaluation of some N-[5-(2-furanyl)-2-methyl-4-oxo-4H-thieno [2,3-d]pyrimidin-3-yl]-carbox-amide and 3-substituted-5-(2-furanyl)-2-methyl-3H-thieno [2,3-d]pyrimidin-4-ones as antimicrobial agents. Eur. J. Med. Chem., 2003, 38, 89-100.
[10]
Al-Omar, M.A.; Amr, A.E. Synthesis of some new pyridine-2,6-carboxamide-derived schiff bases as potential antimicrobial agents. Molecules, 2010, 15(7), 4711-4721.
[11]
Khalifa, N.M.; Al-Omar, M.A.; Amr, A.E.; Haiba, M.E. HIV-1 and HSV-1 virus activities of some new polycyclic nucleoside pyrene candidates. Int. J. Biol. Macromol., 2013, 54, 51-56.
[12]
Abdel Wahab, B.F.; Mohamed, S.F.; Amr, A.E.; Abdalla, M.M. Synthesis and reactions of thiosemicarbazides, triazoles, and Schiff bases as antihypertensive α-blocking agents. Monatsh. Chem., 2008, 139, 1083-1090.
[13]
Alagarsamy, V.; Meena, S.; Ramseshu, K.V.; Solomon, V.R.; Thirumurugan, K.; Dhanabal, K.; Murugan, M. Synthesis, analgesic, anti-inflammatory, ulcerogenic index and anti-bacterial activities of novel 2-methylthio-3-substituted-5,6,7,8-tetrahydrobenzo (b) thieno [2,3-d]pyrimidin-4(3H)-ones. Eur. J. Med. Chem., 2006, 41, 1293-1300.
[14]
Deng, J.F.; Peng, L.; Zhang, G.C.; Lan, X.B.; Li, C.F.; Chen, F.X.; Zhou, Y.Y.; Lin, Z.X.; Chen, L.; Dai, R.K.; Xu, H.J.; Yang, L.; Zhang, X.Q.; Hu, W.H. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes. Eur. J. Med. Chem., 2011, 46, 71-76.
[15]
Horiuchi, T.; Nagata, M.; Kitagawa, M.; Akahane, K.; Uoto, K. Discovery of novel thieno [2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2. Bioorg. Med. Chem., 2009, 17, 7850-7860.
[16]
Aly, A.A.; Brown, A.B.; Ramadan, M.; Gamal-Eldeen, A.M.; Abdel-Aziz, M.; Abuo-Rahma, G.E.D.A.A.; Radwan, M.F. Thieno [2,3-d]pyrimidines in the synthesis of antitumor and antioxidant agents. Archiv Der Pharmazie, 2010, 343, 301-309.
[17]
Al-Taisan, K.M.; Al-Hazimi, H.M.A.; Al-Shihry, S.S. Synthesis, characterization and biological studies of some novel thieno [2,3-d]pyrimidines. Molecules, 2010, 15, 3932-3957.
[18]
Rashad, A.E.; Shamroukh, A.H.; Abdel-Megeid, R.E.; Mostafa, A.; El-Shesheny, R.; Kandeil, A.; Ali, M.A.; Banert, K. Synthesis and screening of some novel fused thiophene and thienopyrimidine derivatives for anti-avian influenza virus (H5N1) activity. Eur. J. Med. Chem., 2010, 45, 5251-5257.
[19]
Patil, V.D.; Wise, D.S.; Townsend, L.B. The synthesis of thieno [2,3-d]pyrimidine nucleosides related to the naturally occurring nucleosides cytidine and uridine. J. Chem. Soc-Perkin Trans, 1980, 1, 1853-1858.
[20]
Amr, A.E.; Abdel-Latif, N.A.; Abdalla, M.M. Synthesis of some new testosterone derivatives fused with substituted pyrazoline ring as promising 5alpha-reductase inhibitors. Acta Pharm., 2006, 56, 203-218.
[21]
Amr, A.E.; Abou-Ghalia, M.H.; Abdallah, M.M. Synthesis of new (Nalpha-dipicolinoyl)-bis-L-valyl-L-phenylalanyl linear and macrocyclic bridged peptides as anti-inflammatory agents. Arch. Pharm. Chem. Life Sci, 2007, 340, 304-309.
[22]
Amr, A.E.; Sayed, H.H.; Abdalla, M.M. Synthesis and reactions of some new substituted pyridine and pyrimidine derivatives as analgesic, anticonvulsant and antiparkinsonian agents. Arch. Pharm. Chem. Life Sci., 2005, 338, 433-440.
[23]
Altamimi, A.S.; Alafeefy, A.M.; Balode, A.; Vozny, I.; Pustenko, A.; El Shikh, M.E.; Alasmary, F.A.S.; Abdel-Gawad, S.A.; Žalubovskis, R. Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A. J. Enzyme Inhib. Med. Chem., 2017, 33, 147-150.
[24]
Molegro Virtual Docker (MVD 2013.6.0.0), Molegro bioinformatics
solutions, 2013, (Danish). http://www.molegro.com
[26]
Marvinsketch, “version 6.1.0, Chemaxon company cheminformatics
technology products services,” 2013 http://www.chemaxon.com/
[27]
Purkey, H.E.; Robarge, K.; Chen, J.; Chen, Z.; Corson, L.B.; Ding, C.Z.; DiPasquale, A.G.; Dragovich, P.S.; Eigenbrot, C.; Evangelista, M.; Fauber, B.P.; Gao, Z.; Ge, H.; Hitz, A.; Ho, Q.; Labadie, S.S.; Lai, K.W.; Liu, W.; Liu, Y.; Li, C.; Ma, S.; Malek, S.; O’Brien, T.; Pang, J.; Peterson, D.; Salphati, L.; Sideris, S.; Ultsch, M.; Wei, B.; Yen, I.; Yue, Q.; Zhang, H.; Zhou, A. Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice. ACS Med. Chem. Lett., 2016, 7, 896-901.
[28]
Mathew, V.; Keshavayya, J.; Vaidya, V.P. Heterocyclic system containing bridgehead nitrogen atom: synthesis and pharmacological activities of some substituted 1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles. Eur. J. Med. Chem., 2006, 41, 1048-1058.
[29]
Manerba, M.; Vettraino, M.; Fiume, L.; Di Stefano, G.; Sartini, A.; Giacomini, E.; Buonfiglio, R.; Roberti, M.; Recanatini, M. Galloflavin (CAS 568-80-9): A novel inhibitor of lactate dehydrogenase. ChemMedChem, 2012, 7, 311-317.
[30]
Farabegoli, F.; Vettraino, M.; Manerba, M.; Fiume, L.; Roberti, M.; Di Stefano, G. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. Eur. J. Pharm. Sci., 2012, 47, 729-738.
[31]
Vettraino, M.; Manerba, M.; Govoni, M.; Di Stefano, G. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1. Anticancer Drugs, 2013, 24, 862-870.
[32]
Manerba, M.; Di Ianni, L.; Fiume, L.; Roberti, M.; Recanatini, M.; Di Stefano, G. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. Eur. J. Pharm. Sci., 2015, 74, 95-102.
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Therapeutic Use of Plant Secondary Metabolites
Therapeutic Implications of Natural Bioactive Compounds
Frontiers in Bioactive Compounds
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Article Metrics
36
4